
On this page
10 min read
Postural orthostatic tachycardia syndrome (POTS) is a disorder of the autonomic nervous system, characterised by symptoms of orthostatic intolerance and an excessive increase in heart rate when standing.1 In adults, POTS is diagnosed by a sustained increase in heart rate of at least 30 beats per minute on an orthostatic challenge test (an Active Stand Test or Head Up Tilt Test), in the absence of sustained orthostatic hypotension, together with symptoms of orthostatic intolerance. In adolescents aged 12–19 years, the increase in heart rate is at least 40 beats per minute.2,3
POTS can affect people across the lifespan but is more common in women of childbearing age. Symptoms may fluctuate substantially over time, with periods of relative stability and episodes of significant exacerbation.1 The 2026 State-of-the-Art Review provides a contemporary overview of POTS, including its clinical presentation, diagnosis, investigation and management, and highlights the importance of multidisciplinary care.1
Consider POTS in people with recurrent symptoms that are triggered or worsened by standing and improve with sitting or lying down.
Common symptoms include:
Symptoms can be highly variable and can be orthostatic and non-orthostatic in nature. Some people experience relatively mild symptoms, whereas others develop substantial limitations in physical activity, education, employment and participation in everyday activities.1–3
POTS is a clinical diagnosis based on the patient's history, physical examination and assessment of the cardiovascular response to standing with an orthostatic challenge test.1–3
An active stand test can usually be performed in primary care or other clinical settings.1,2
Points for consideration:1,2
In adults, POTS is characterised by:
A sustained increase (2 consecutive measurements that are one minute apart) in heart rate of ≥30 beats per minute during 10 minutes of standing, without sustained orthostatic hypotension, accompanied by symptoms of orthostatic intolerance. In adolescents, the heart rate increase should be ≥40 beats per minute.2,3
The heart rate response should be interpreted in the context of the clinical presentation. A single negative assessment does not necessarily exclude POTS when clinical suspicion remains high, as such repeat assessment or specialist evaluation may be appropriate. 2
A tilt-table test is not routinely required for diagnosis but may be useful in select patients where the diagnosis remains uncertain or in instances of inconclusive active stand measurements.3
Investigations should be guided by the clinical presentation and used to identify alternative or contributing causes of tachycardia and orthostatic symptoms.1–3
Depending on the presentation, investigations may include:
Additional investigations or specialist autonomic testing may be appropriate in selected patients.
Wearable devices can provide useful information about heart-rate patterns but should not be used in isolation to establish a diagnosis of POTS.1
An increase in heart rate on standing is not specific to POTS.
Consider other causes of orthostatic tachycardia or similar symptoms, including:1–3
A medication review is an important component of assessment, particularly where medicines may affect heart rate, blood pressure or circulating blood volume.
There is no single treatment that is effective for everyone with POTS.
Management should be individualised according to symptoms, cardiovascular profile, functional capacity, comorbidities and patient preferences.1–3
Education is an important component of POTS management.
Patients should understand the relationship between posture, symptoms and heart rate and identify individual factors that worsen or improve their symptoms.
Treatment strategies1–3 include:
Exercise programs should be individualised according to baseline functional capacity, symptom severity and comorbidities. For people with significant orthostatic intolerance or exercise limitation, an initial program may involve recumbent or semi-recumbent exercise before gradually progressing towards upright exercise as tolerated.1–3
A physiotherapist, accredited exercise physiologist or other clinician experienced in exercise rehabilitation should be engaged to assist with developing and progressing an appropriate program. Exercise should be introduced gradually and monitored according to symptoms and functional response.1-3
Pharmacological treatment may be considered when symptoms remain troublesome despite appropriate non-pharmacological management.1–3
Depending on the clinical presentation, medicines used in POTS may include:1–3
Medicines used to treat POTS in Australia are off-label and may be cost prohibitive for some people.
POTS is a disorder of autonomic cardiovascular regulation and is not, in itself, evidence of structural heart disease. However, people with POTS may experience cardiovascular symptoms including palpitations, chest discomfort, breathlessness, dizziness and exercise intolerance. These symptoms should be assessed in their clinical context and should not automatically be attributed to POTS. Healthcare professionals should continue to assess cardiovascular risk and investigate symptoms suggestive of other cardiac conditions when clinically indicated.1–3
New or unexplained chest pain, sustained arrhythmia, haemodynamic instability or concerning syncope should be appropriately investigated rather than attributed to POTS without assessment.1
POTS may develop following an acute illness or infection. POTS has been increasingly recognised following COVID-19 infection and within the broader spectrum of post-acute sequelae of SARS-CoV-2 infection and is a recognised presentation of Long COVID.4,5
POTS has also been reported following COVID-19 vaccination, although evidence for a causal relationship remains limited. 4-6
However, POTS can occur following a range of potential triggers including hormonal change, viral infection, concussion, and traumatic events and may also develop without an identifiable precipitating factor. 1
POTS can affect multiple aspects of physical and psychosocial functioning. Management may therefore involve several healthcare professionals.1
Depending on the individual's needs, this may include:
Primary care can play an important role in coordinating care, monitoring symptoms, reviewing medications, managing cardiovascular risk factors and facilitating appropriate specialist and allied health referrals.
Consider specialist assessment when:1–3
Urgent assessment is appropriate for symptoms suggestive of an acute or serious cardiovascular condition, including new or unexplained chest pain, sustained arrhythmia, haemodynamic instability or concerning syncope.
Australian POTS Foundation – POTS for Practitioners webinar series
potsfoundation.org.au/the-knowledge-hub  Evidence-based information and practical resources for health professionals on recognising, assessing and managing POTS. Â
Access practical clinical tools including the Active Stand Test template, How to Undertake and Interpret the Active Stand Test information sheet, Active Stand Test instructional video and GP POTS Resource Sheet.Â
Information for health professionals about non-pharmacological management, pharmacological treatment and multidisciplinary care. potsfoundation.org.au/the-knowledge-hub/?_sft_journalCat=non-pharmacological-treatmentÂ
The Australian POTS Foundation is an RACGP-registered CPD provider. Access professional education, including the recorded webinar on the diagnosis and management of POTS in primary care. potsfoundation.org.au/cpdÂ
Search clinical guidance, peer-reviewed research, webinars, conference presentations, information sheets and other evidence-based POTS resources.Â
Lau DH, Fedorowski A, Raj SR, et al. Postural Orthostatic Tachycardia Syndrome: A State-of-the-Art Review. Heart Lung Circ. 2026;35:171–185.Â
This contemporary State-of-the-Art Review provides a comprehensive overview of the clinical presentation, diagnosis and management of POTS.Â
1. Lau DH, Fedorowski A, Raj SR, et al. Postural Orthostatic Tachycardia Syndrome: A State-of-the-Art Review. Heart Lung Circ 2026;35:171-185. doi: 10.1016/j.hlc.2025.09.004Â
2. Raj SR, Guzman JC, Harvey P, et al. Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance. Can J Cardiol 2020;36:357-372. doi: 10.1016/j.cjca.2019.12.024Â
3. Sheldon RS, Grubb BP, 2nd, Olshansky B, et al. 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm 2015;12:e41-63. doi: 10.1016/j.hrthm.2015.03.029Â
4. Seeley MC, Gallagher C, Ong E, et al. High Incidence of Autonomic Dysfunction and Postural Orthostatic Tachycardia Syndrome in Patients with Long COVID: Implications for Management and Health Care Planning. Am J Med 2025;138:354-361 e351. doi: 10.1016/j.amjmed.2023.06.010Â
5. Seeley MC, Wilson G, Ong E, Langdon A, Chieng J, Bailey D, et al. Multimorbidity, functional impairment and health-related quality of life in postural orthostatic tachycardia syndrome: findings from an Australian observational cohort study. BMJ Open. 2026;16(9):e119165. doi:10.1136/bmjopen-2025-119165Â
6. Kwan, A.C., Ebinger, J.E., Wei, J. et al. Apparent risks of postural orthostatic tachycardia syndrome diagnoses after COVID-19 vaccination and SARS-Cov-2 Infection. Nat Cardiovasc Res 1, 1187–1194 (2022). https://doi.org/10.1038/s44161-022-00177-8Â
Â
Last updated03 November 2026
Last reviewed20 October 2026